Apogent Technologies Inc. Announces Acquisition Of Disposable Culture Tube Business of Kimble Glass Inc.

Apr 10, 2001, 01:00 ET from Apogent Technologies Inc.

    PORTSMOUTH, N.H., April 10 /PRNewswire/ --
 Apogent Technologies Inc. (NYSE:   AOT) announced today that it acquired the
 disposable glass culture tube business ("DCT Business") of Kimble Glass Inc.
 ("Kimble"), currently located in Vineland, New Jersey.  The DCT Business will
 be owned by and consolidated into Apogent's subsidiary, Chase Scientific
 Glass, Inc. ("Chase"), which currently manufactures DCTs.
     Disposable glass culture tubes ("DCTs") are used in a variety of general
 laboratory applications, particularly in blood collection, blood banking,
 urinalysis and certain cell culture procedures.  DCTs are manufactured on
 horizontal glass bottoming machines from borosilicate and soda lime glass
 tubing stock.
     The acquisition of Kimble's DCT Business line will strengthen Chase's
 position in the DCT market and provide Chase with improved plant/equipment
 utilization and overhead absorption.
     Stephen K. Wiatt, Executive Vice President-Worldwide Glass Operations
 stated, "The addition of Kimble's DCT product line will enhance our position
 in the DCT market and enable Chase Scientific to expand in one of its core
 competency areas."
     Commenting on the DCT Business acquisition, Apogent's President and CEO,
 Frank H. Jellinek, Jr. said, "The DCT Business acquisition creates a positive
 opportunity to increase production and sales in one of our current product
 lines to better serve the clinical and industrial market."
 
     Upcoming Events
     On Tuesday, April 24, 2001 at 11 A.M. EDT, Apogent expects to host a
 conference call to discuss its second fiscal quarter financial results for the
 period ended March 31, 2001.
     The dial-in numbers for the teleconference will be:
 
     Domestic Callers       (800) 582-6982
     International Callers  (212) 748-2711
 
     The conference call will also be audio webcast on Apogent's website in the
 Investor Relations section at www.apogent.com .
     On Tuesday, May 15, 2001, Apogent management will be presenting at the
 Robert W. Baird Growth Stock Conference at 1:35 PM CDT at the Four Seasons
 Hotel in Chicago, Illinois.  For further information on this presentation
 including a copy of the written presentation materials, again please visit the
 Investor Relations section of Apogent's website at www.apogent.com .
 
     Business Description
     Apogent's subsidiaries design, manufacture and market value-added
 laboratory and life science products for the clinical, research and industrial
 markets, worldwide.  The Company's lines of business include Labware and Life
 Sciences, Diagnostics and Microbiology, Clinical and Industrial, and
 Laboratory Equipment.
     Apogent's broad array of industry leading products includes Nalge Nunc
 International reusable and disposable multi-well plates and plastic labware;
 Microgenics drug testing products; Applied Biotech rapid diagnostic tests;
 Erie Scientific coated and printed glass for clinical diagnostics and
 microarray applications; Richard-Allan Scientific histology and
 immunohistochemistry consumables and equipment; and Barnstead Thermolyne
 laboratory equipment and water systems.
 
     Note Regarding Forward-Looking Statements
     This press release contains forward-looking statements as defined under
 Federal securities laws, including statements concerning the Company's
 strategic and financial goals and market growth that involve risks and
 uncertainties.  These and other statements that relate to future results and
 events are based on the Company's current expectations.  Actual results may
 differ materially from those presently anticipated.  Factors that could cause
 actual results to differ materially include the "Cautionary Factors" contained
 in the Company's Form 10-K filed with the Securities and Exchange Commission
 for the fiscal year ended September 30, 2000 and its subsequent report(s) on
 Form 10Q.  We undertake no obligation to publicly update any forward-looking
 statement, whether as a result of new information, future events or otherwise.
 
 

SOURCE Apogent Technologies Inc.
    PORTSMOUTH, N.H., April 10 /PRNewswire/ --
 Apogent Technologies Inc. (NYSE:   AOT) announced today that it acquired the
 disposable glass culture tube business ("DCT Business") of Kimble Glass Inc.
 ("Kimble"), currently located in Vineland, New Jersey.  The DCT Business will
 be owned by and consolidated into Apogent's subsidiary, Chase Scientific
 Glass, Inc. ("Chase"), which currently manufactures DCTs.
     Disposable glass culture tubes ("DCTs") are used in a variety of general
 laboratory applications, particularly in blood collection, blood banking,
 urinalysis and certain cell culture procedures.  DCTs are manufactured on
 horizontal glass bottoming machines from borosilicate and soda lime glass
 tubing stock.
     The acquisition of Kimble's DCT Business line will strengthen Chase's
 position in the DCT market and provide Chase with improved plant/equipment
 utilization and overhead absorption.
     Stephen K. Wiatt, Executive Vice President-Worldwide Glass Operations
 stated, "The addition of Kimble's DCT product line will enhance our position
 in the DCT market and enable Chase Scientific to expand in one of its core
 competency areas."
     Commenting on the DCT Business acquisition, Apogent's President and CEO,
 Frank H. Jellinek, Jr. said, "The DCT Business acquisition creates a positive
 opportunity to increase production and sales in one of our current product
 lines to better serve the clinical and industrial market."
 
     Upcoming Events
     On Tuesday, April 24, 2001 at 11 A.M. EDT, Apogent expects to host a
 conference call to discuss its second fiscal quarter financial results for the
 period ended March 31, 2001.
     The dial-in numbers for the teleconference will be:
 
     Domestic Callers       (800) 582-6982
     International Callers  (212) 748-2711
 
     The conference call will also be audio webcast on Apogent's website in the
 Investor Relations section at www.apogent.com .
     On Tuesday, May 15, 2001, Apogent management will be presenting at the
 Robert W. Baird Growth Stock Conference at 1:35 PM CDT at the Four Seasons
 Hotel in Chicago, Illinois.  For further information on this presentation
 including a copy of the written presentation materials, again please visit the
 Investor Relations section of Apogent's website at www.apogent.com .
 
     Business Description
     Apogent's subsidiaries design, manufacture and market value-added
 laboratory and life science products for the clinical, research and industrial
 markets, worldwide.  The Company's lines of business include Labware and Life
 Sciences, Diagnostics and Microbiology, Clinical and Industrial, and
 Laboratory Equipment.
     Apogent's broad array of industry leading products includes Nalge Nunc
 International reusable and disposable multi-well plates and plastic labware;
 Microgenics drug testing products; Applied Biotech rapid diagnostic tests;
 Erie Scientific coated and printed glass for clinical diagnostics and
 microarray applications; Richard-Allan Scientific histology and
 immunohistochemistry consumables and equipment; and Barnstead Thermolyne
 laboratory equipment and water systems.
 
     Note Regarding Forward-Looking Statements
     This press release contains forward-looking statements as defined under
 Federal securities laws, including statements concerning the Company's
 strategic and financial goals and market growth that involve risks and
 uncertainties.  These and other statements that relate to future results and
 events are based on the Company's current expectations.  Actual results may
 differ materially from those presently anticipated.  Factors that could cause
 actual results to differ materially include the "Cautionary Factors" contained
 in the Company's Form 10-K filed with the Securities and Exchange Commission
 for the fiscal year ended September 30, 2000 and its subsequent report(s) on
 Form 10Q.  We undertake no obligation to publicly update any forward-looking
 statement, whether as a result of new information, future events or otherwise.
 
 SOURCE  Apogent Technologies Inc.